2-[1-hydroxy-6-(oxolan-2-ylmethoxy)isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-thiazole-4-carboxamide
C26H28N6O4S — CID 91294265
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[1-hydroxy-6-(oxolan-2-ylmethoxy)isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-thiazole-4-carboxamide
2-[1-hydroxy-6-(oxolan-2-ylmethoxy)isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-thiazole-4-carboxamide (PubChem CID 91294265) has the molecular formula C26H28N6O4S and a molecular weight of 520.62 g/mol. Its IUPAC name is 2-[1-hydroxy-6-(oxolan-2-ylmethoxy)isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-thiazole-4-carboxamide.
Molecular Properties
| Compound Name | 2-[1-hydroxy-6-(oxolan-2-ylmethoxy)isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-thiazole-4-carboxamide |
|---|---|
| PubChem CID | 91294265 |
| Molecular Formula | C26H28N6O4S |
| Molecular Weight | 520.62 g/mol |
| Exact Mass | 520.19 |
| IUPAC Name | 2-[1-hydroxy-6-(oxolan-2-ylmethoxy)isoindol-2-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3-thiazole-4-carboxamide |
| SMILES | O=C(Nc1cnccc1N1CCNCC1)c1csc(-n2cc3ccc(OCC4CCCO4)cc3c2O)n1 |
| InChI | InChI=1S/C26H28N6O4S/c33-24(29-21-13-28-6-5-23(21)31-9-7-27-8-10-31)22-16-37-26(30-22)32-14-17-3-4-18(12-20(17)25(32)34)36-15-19-2-1-11-35-19/h3-6,12-14,16,19,27,34H,1-2,7-11,15H2,(H,29,33) |
| InChIKey | XPCUZVODODLAAI-UHFFFAOYSA-N |
| XLogP | 3.41 |
| TPSA | 113.77 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 520.62 |
| LogP ≤ 5 | 3.41 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91294265 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.